
News|Videos|October 7, 2026
Why Pharma Is Automating for Resilience
Author(s)Garrett Freeman, Stephen Appezzato
At LogiPharma USA 2026, Swisslog's Garrett Freeman explains how onshoring, geopolitical risk and a shifting product mix are driving supply chain automation.
Advertisement
Advertisement
According to Garrett Freeman, sales director at Swisslog, the business case for automation in pharmaceutical supply chains has changed. Speaking with Pharmaceutical Commerce at
Related to this article

Octapharma USA's Kerem Tokel, a LogiPharma USA 2026 freight security panelist, discusses theft hotspots, the export of stolen pharmaceutical loads and how to tighten chain of custody.

At LogiPharma USA 2026, Mark Talens explains how end-to-end visibility lets pharma see its value chain across functions, and where supply chain monitoring is headed next.

In Episode 2, Part 4, Cheryl Allen, Nick Calla and Rena Goins discuss how the industry is building channels around complex products.

Asembia's Ray Tancredi explains why manufacturer and specialty pharmacy trade talks now center on getting patients on therapy.

In Episode 2, Part 3, Cheryl Allen, Nick Calla and Rena Goins discuss where manufacturers should start when evaluating the channel.

In this week’s Pharma Pulse, the FDA launches a program that lets companies share its approval packages with foreign regulators, UPS agrees to acquire Australia and New Zealand health care courier Smartways Logistics and Cognizant introduces an AI-enabled patient hub offering.

McKesson's Gene Cavacini on how pharmaceutical distributors manage drug shortages, DSCSA requirements and cold-chain capacity to keep medicines moving.
Advertisement
Advertisement

